Information  X 
Enter a valid email address

MySQUAR Limited (MYSQ)

  Print      Mail a friend

Monday 05 November, 2018

MySQUAR Limited

Suspension of Trading

RNS Number : 2699G
MySQUAR Limited
05 November 2018

5 November 2018

MySQUAR Limited 

("MySQUAR" or the "Company") 


Suspension of Trading


The Company announces that it has requested the suspension of trading on AIM of the ordinary shares ("Shares") of no par value in the capital of the Company with effect from 7.30am today pending the clarification of the Company's financial position. This follows a review of the account into which the proceeds were paid of the bond issues announced on 7th March 2018 and 20th June 2018.

The Company's cash balances are very low and it has sought to draw down on the $1m facility from Rising Dragon Singapore Pte Limited without success.  As a consequence there is material uncertainty regarding the Company's working capital position. 

The Company has also withdrawn the application for admission to trading on AIM of the 171,428,571 Shares issued by way of a placing announced on 30th October 2018.

The Company is continuing to investigate the above matters and further announcements will be made as soon as practicable.


Market Abuse Regulation (MAR) Disclosure

Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 until the release of this announcement.


For further information:


MySQUAR Limited

Stephen Chong (Interim Chief Executive)

Tel: +65 6725 6388

SP Angel Corporate Finance LLP

Nominated Adviser & Joint Broker

Tel:  +44 (0) 203 470 0470

Stuart Gledhill / Soltan Tagiev 

Daniel Stewart and Company Plc

Joint Broker

Tel: +44 (0) 207 776 6550

David Lawman/Jon Levinson/Daphne



SVS Securities plc

Joint Broker


Tom Curran


+44 (0) 203 700 0093

Public Relations

 Tel:  +44 (0) 781 677 0758

Damien McCrystal

[email protected]




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

a d v e r t i s e m e n t